A detailed history of Breed'S Hill Capital LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Breed'S Hill Capital LLC holds 8,087 shares of ABT stock, worth $929,924. This represents 0.76% of its overall portfolio holdings.

Number of Shares
8,087
Previous 8,061 0.32%
Holding current value
$929,924
Previous $838 Million 10.07%
% of portfolio
0.76%
Previous 0.74%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$100.07 - $118.13 $2,601 - $3,071
26 Added 0.32%
8,087 $922 Million
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $7,666 - $8,467
-70 Reduced 0.86%
8,061 $916 Million
Q4 2023

Feb 06, 2024

BUY
$90.19 - $110.4 $733,334 - $897,662
8,131 New
8,131 $895 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Breed'S Hill Capital LLC Portfolio

Follow Breed'S Hill Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Breed'S Hill Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Breed'S Hill Capital LLC with notifications on news.